TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Clinical trial NCT03732235 · UNKNOWN
Trial details
- NCT number
- NCT03732235
- Sponsor
- Giammaria Fiorentini
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-01
- Primary completion
- 2021-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.